RNA-Immunotherapy of IVAC_W_bre1_uID and IVAC_M_uID
Clinical trial NCT02316457 · COMPLETED
Trial details
- NCT number
- NCT02316457
- Sponsor
- BioNTech SE
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-01
- Primary completion
- 2020-05-13
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.